Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
347.52
+10.17 (3.01%)
Jan 21, 2025, 4:00 PM EST - Market closed
Medpace Holdings Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Medpace Holdings stock have an average target of 389, with a low estimate of 336 and a high estimate of 480. The average target predicts an increase of 11.94% from the current stock price of 347.52.
Analyst Consensus: Buy
* Price targets were last updated on Nov 25, 2024.
Analyst Ratings
The average analyst rating for MEDP stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 4 | 4 | 4 | 4 | 4 |
| Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Hold | 2 | 4 | 5 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 10 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Hold Maintains $349 → $354 | Hold | Maintains | $349 → $354 | +1.86% | Nov 25, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $413 → $372 | Strong Buy | Maintains | $413 → $372 | +7.04% | Oct 23, 2024 |
| Baird | Baird | Buy → Hold Downgrades $413 → $349 | Buy → Hold | Downgrades | $413 → $349 | +0.43% | Oct 23, 2024 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Oct 22, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $415 → $397 | Hold | Maintains | $415 → $397 | +14.24% | Oct 14, 2024 |
Financial Forecast
Revenue This Year
2.15B
from 1.89B
Increased by 13.95%
Revenue Next Year
2.27B
from 2.15B
Increased by 5.49%
EPS This Year
12.18
from 8.88
Increased by 37.19%
EPS Next Year
12.80
from 12.18
Increased by 5.09%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 2.2B | 2.5B | 2.7B | |||
| Avg | 2.1B | 2.3B | 2.5B | |||
| Low | 2.1B | 2.2B | 2.3B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 17.6% | 14.1% | 19.7% | |||
| Avg | 14.0% | 5.5% | 12.0% | |||
| Low | 9.1% | 0.1% | 3.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 12.79 | 14.07 | 16.85 | |||
| Avg | 12.18 | 12.80 | 14.71 | |||
| Low | 11.52 | 11.93 | 13.30 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 44.0% | 15.5% | 31.6% | |||
| Avg | 37.2% | 5.1% | 14.9% | |||
| Low | 29.8% | -2.0% | 3.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.